MGNX

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

MacroGenics (MGNX) Earnings Date & Reports

Industry: @Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

MGNX is expected to report earnings to fall 144.48% to -40 cents per share on March 04

Q4'24

Est.

$-0.40

Q3'24

Beat

by $0.69

Q2'24

Missed

by $0.23

Q1'24

Missed

by $0.20

Q4'23

Est.

$-0.15

The last earnings report on November 05 showed earnings per share of 89 cents, beating the estimate of 20 cents. With 878.10K shares outstanding, the current market capitalization sits at 200.84M.

View a ticker or compare two or three

Compare

MGNX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For MGNX
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for MGNX (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a company, which engages in the discovery and development of monoclonal antibody-based therapeutics

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

9704 Medical Center Drive

Phone

+1 301 251-5172

Employees

339

Web

https://www.macrogenics.com